Trial Profile
Proteomic profiling for influenza vaccination, 2nd study: Flumist
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 08 May 2008
Price :
$35
*
At a glance
- Drugs Influenza virus vaccine live (Primary)
- Indications Influenza virus infections
- Focus Pharmacodynamics
- 08 May 2008 New trial record.